Publication | Closed Access

GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture

Prognostic BiomarkersUrologyOncologyBiochemical RecurrenceGenitourinary CancerProstate Cancer NegativeMedicinePathologyCancer GenomicsGbx2 MethylationProstatic DiseaseMolecular Diagnostics